Market Research Logo

Romania Pharmaceuticals & Healthcare Q1 2019

Romania Pharmaceuticals & Healthcare Q1 2019

Key View:

The drug pricing environment, exemplified by the clawback tax, continues to pose considerable risks for drugmakers,limiting the Romanian pharmaceutical market's attractiveness. Access to medicines is poor, with a severe lack of public healthcarefinancing shifting the burden of costs onto patients. Having said this, pharmaceutical market growth remains on a robust trajectory,outperforming all EU member states, due to low levels of spending and shifting demand dynamics.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Romania Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Antibiotice Iasi
LaborMed Pharma
Terapia
Romania Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report